Bionsight Selected to Pitch at BioTools Innovator 2026
Bionsight has been selected to pitch at the BioTools Innovator 2026 Road Tour, joining roughly 15% of global applicants invited to present to investors and industry leaders.
Read more →Stay updated with our latest developments, research breakthroughs, and company announcements
Bionsight has been selected to pitch at the BioTools Innovator 2026 Road Tour, joining roughly 15% of global applicants invited to present to investors and industry leaders.
Read more →We are excited to launch our new website and share our vision for revolutionizing drug discovery through AI and chemoproteomics.
Read more →Selected for the “Scale-up TIPS” program by the Ministry of SMEs and Startups
Read more →Successfully raises Series A funding for drug discovery innovation
Read more →Bionsight selected as the finalist team in 2022 Merck Research Grants.
Read more →